These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9059395)
1. Brain lesion contrast in MR imaging. Dependence on field strength and concentration of gadodiamide injection in patients and phantoms. Akeson P; Vikhoff B; Ståhlberg F; Holtås S Acta Radiol; 1997 Jan; 38(1):14-8. PubMed ID: 9059395 [TBL] [Abstract][Full Text] [Related]
2. Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging. Akeson P; Larsson EM; Kristoffersen DT; Jonsson E; Holtås S Acta Radiol; 1995 May; 36(3):300-6. PubMed ID: 7742127 [TBL] [Abstract][Full Text] [Related]
3. Time-dependency in brain lesion enhancement with gadodiamide injection. Akeson P; Nordström CH; Holtås S Acta Radiol; 1997 Jan; 38(1):19-24. PubMed ID: 9059396 [TBL] [Abstract][Full Text] [Related]
4. Gd-enhanced MR imaging of brain metastases: contrast as a function of dose and lesion size. Van Dijk P; Sijens PE; Schmitz PI; Oudkerk M Magn Reson Imaging; 1997; 15(5):535-41. PubMed ID: 9253997 [TBL] [Abstract][Full Text] [Related]
5. [Gadodiamide and gadolinium-DTPA as intravenous media in computed tomography]. Engelbrecht V; Koch JA; Rassek M; Mödder U Rofo; 1996 Jul; 165(1):24-8. PubMed ID: 8765359 [TBL] [Abstract][Full Text] [Related]
6. [Use of Omniscan (gadodiamide) in magnetic resonance studies of the central nervous system (results of a multicenter study)]. Sinitsyn VE; Kornienko VN; Nikitin VG; Pronin IN; Ternovoĭ SK; Tiutin LA; Iakobson MG Vestn Rentgenol Radiol; 1995; (4):5-11. PubMed ID: 8571538 [TBL] [Abstract][Full Text] [Related]
7. Improvement of brain lesion detection at 0.1 T by simultaneous use of Gd-DTPA and magnetization transfer imaging. Ramadan UA; Aronen HJ; Tanttu JI; Karjalainen PT; Kairemo KJ; Jääskeläinen J; Sipilä L; Häkkinen AM Magn Reson Med; 1997 Feb; 37(2):268-74. PubMed ID: 9001152 [TBL] [Abstract][Full Text] [Related]
8. Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T. Chang KH; Ra DG; Han MH; Cha SH; Kim HD; Han MC AJNR Am J Neuroradiol; 1994 Sep; 15(8):1413-9; discussion 1420-3. PubMed ID: 7985558 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study. Svaland MG; Christensen T; Lundorf E Acta Radiol; 1994 Jul; 35(4):396-9. PubMed ID: 8011392 [TBL] [Abstract][Full Text] [Related]
10. MR imaging of pituitary region lesions with gadodiamide injection. Hald JK; Skalpe IO; Bakke SJ; Nakstad PH Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277 [TBL] [Abstract][Full Text] [Related]
11. Gadolinium-enhanced 3D time-of-flight MR angiography. Experimental and clinical evaluation. Yano T; Kodama T; Suzuki Y; Watanabe K Acta Radiol; 1997 Jan; 38(1):47-54. PubMed ID: 9059401 [TBL] [Abstract][Full Text] [Related]
12. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents. Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078 [TBL] [Abstract][Full Text] [Related]
13. MR imaging in recurrent pain after back surgery. A comparative study using standard and high doses of gadolinium contrast agents. Akeson P; Annertz M; Kristoffersen DT; Jonsson E; Holtas S Acta Radiol; 1996 Nov; 37(6):858-62. PubMed ID: 8995455 [TBL] [Abstract][Full Text] [Related]
14. Analysis of magnetization transfer effects on T1-weighted spin-echo scans using a simple tissue phantom simulating gadolinium-enhanced brain lesions. Finelli DA; Hurst GC; Frank HA; Gullapali RP; Apicella A J Magn Reson Imaging; 1997; 7(4):731-8. PubMed ID: 9243395 [TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging contrast media in the subarachnoid space. A comparison between gadodiamide injection and gadopentetate dimeglumine in an experimental study in pigs. Skalpe IO; Tang GJ Invest Radiol; 1997 Mar; 32(3):140-8. PubMed ID: 9055126 [TBL] [Abstract][Full Text] [Related]
16. Magnetization transfer effects on T1-weighted three-dimensional gradient-echo MR images of a phantom simulating enhancing brain lesions. Finelli DA AJNR Am J Neuroradiol; 1997 Jan; 18(1):147-59. PubMed ID: 9010534 [TBL] [Abstract][Full Text] [Related]
17. [High dosage Gd-DPTA-BMA (Gadodiamid) administration in diagnosis and therapeutic monitoring of malignant bone tumors]. Häussler MD; Rummeny EJ; Raufhake C; Blasius S; Lindner N; Daldrup HE; Reimer P; Peters PE Radiologe; 1996 Feb; 36(2):148-52. PubMed ID: 8867432 [TBL] [Abstract][Full Text] [Related]
18. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats. Tweedle MF; Wedeking P; Kumar K Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190 [TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance renography: optimisation of pulse sequence parameters and Gd-DTPA dose, and comparison with radionuclide renography. Taylor J; Summers PE; Keevil SF; Saks AM; Diskin J; Hilton PJ; Ayers AB Magn Reson Imaging; 1997; 15(6):637-49. PubMed ID: 9285803 [TBL] [Abstract][Full Text] [Related]
20. MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction. Dulce MC; Duerinckx AJ; Hartiala J; Caputo GR; O'Sullivan M; Cheitlin MD; Higgins CB AJR Am J Roentgenol; 1993 May; 160(5):963-70. PubMed ID: 8470611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]